Screening of the most common MEFV variants in 416 patients of familial mediterranean fever living in Northwest of Iran.

IF 1.4 Q3 Pharmacology, Toxicology and Pharmaceutics
Armin Gharibi, Esmaeil Babaei, Ali Vahabi
{"title":"Screening of the most common MEFV variants in 416 patients of familial mediterranean fever living in Northwest of Iran.","authors":"Armin Gharibi, Esmaeil Babaei, Ali Vahabi","doi":"10.4103/JAPTR.JAPTR_22_24","DOIUrl":null,"url":null,"abstract":"<p><p>Familial Mediterranean Fever (FMF) is an inherited disorder with an autosomal recessive pattern of inheritance. FMF is the most prevalent among ethnic populations originating from the Mediterranean region and results from pathogenic mutations in the Mediterranean fever (MEFV) gene. For the materials and methods employed in this study, a total of 416 patients from the northwestern region of Iran were screened for the presence of 18 commonly occurring variants in the MEFV gene. The screening process involved the use of multiplex amplification-ligation polymerase chain reaction coupled with fluorescently labeled DNA probes. This technique enabled the detection of single nucleotide polymorphisms, which are variations in a single nucleotide base within the MEFV gene sequence. The initial manifestation of symptoms occurred between the ages of 1 and 20 years in 63.46% of the cases studied. The four most commonly observed clinical manifestations among the patients were abdominal pain, fever, joint pain, and vomiting. Molecular analysis of 18 prevalent MEFV variants in 416 FMF patients revealed the underlying genetic causes in 242 individuals. Out of these 242 cases, 129 patients (53.3%) were heterozygous carriers of a single pathogenic variant, 19 patients (7.8%) were homozygous for a single variant, 48 patients (19.83%) were compound heterozygotes harboring two different pathogenic variants, and 46 patients (19%) exhibited multiple variants, which were classified as complex cases. The R202Q variation emerged as the most prevalent among the four genotypic groups and exhibited the highest allele frequency (39.94%), followed by E148Q (20.62%), M694V (15.14%), and V726A (15.14%). Genetic profiling of MEFV variations revealed a predominance of R202Q, with E148Q, M694V, and V726A occurring in descending order of frequency. The allele frequency of the R202Q variant exhibited a statistically significant difference when compared to other ethnic groups, with the exception of the Turkish population. Interestingly, while the M694V variant is reported as the most prevalent in several other populations and ethnic groups, in our study cohort, it emerged as the third most common variant. This finding suggests that the frequencies of specific alleles can vary substantially across different countries, populations, and ethnic groups.</p>","PeriodicalId":14877,"journal":{"name":"Journal of Advanced Pharmaceutical Technology & Research","volume":"16 1","pages":"12-17"},"PeriodicalIF":1.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11960822/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Pharmaceutical Technology & Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/JAPTR.JAPTR_22_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Familial Mediterranean Fever (FMF) is an inherited disorder with an autosomal recessive pattern of inheritance. FMF is the most prevalent among ethnic populations originating from the Mediterranean region and results from pathogenic mutations in the Mediterranean fever (MEFV) gene. For the materials and methods employed in this study, a total of 416 patients from the northwestern region of Iran were screened for the presence of 18 commonly occurring variants in the MEFV gene. The screening process involved the use of multiplex amplification-ligation polymerase chain reaction coupled with fluorescently labeled DNA probes. This technique enabled the detection of single nucleotide polymorphisms, which are variations in a single nucleotide base within the MEFV gene sequence. The initial manifestation of symptoms occurred between the ages of 1 and 20 years in 63.46% of the cases studied. The four most commonly observed clinical manifestations among the patients were abdominal pain, fever, joint pain, and vomiting. Molecular analysis of 18 prevalent MEFV variants in 416 FMF patients revealed the underlying genetic causes in 242 individuals. Out of these 242 cases, 129 patients (53.3%) were heterozygous carriers of a single pathogenic variant, 19 patients (7.8%) were homozygous for a single variant, 48 patients (19.83%) were compound heterozygotes harboring two different pathogenic variants, and 46 patients (19%) exhibited multiple variants, which were classified as complex cases. The R202Q variation emerged as the most prevalent among the four genotypic groups and exhibited the highest allele frequency (39.94%), followed by E148Q (20.62%), M694V (15.14%), and V726A (15.14%). Genetic profiling of MEFV variations revealed a predominance of R202Q, with E148Q, M694V, and V726A occurring in descending order of frequency. The allele frequency of the R202Q variant exhibited a statistically significant difference when compared to other ethnic groups, with the exception of the Turkish population. Interestingly, while the M694V variant is reported as the most prevalent in several other populations and ethnic groups, in our study cohort, it emerged as the third most common variant. This finding suggests that the frequencies of specific alleles can vary substantially across different countries, populations, and ethnic groups.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
7.10%
发文量
44
审稿时长
20 weeks
期刊介绍: Journal of Advanced Pharmaceutical Technology & Research (JAPTR) is an Official Publication of Society of Pharmaceutical Education & Research™. It is an international journal published Quarterly. Journal of Advanced Pharmaceutical Technology & Research (JAPTR) is available in online and print version. It is a peer reviewed journal aiming to communicate high quality original research work, reviews, short communications, case report, Ethics Forum, Education Forum and Letter to editor that contribute significantly to further the scientific knowledge related to the field of Pharmacy i.e. Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical Chemistry. Articles with timely interest and newer research concepts will be given more preference.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信